The cause of euploidic embryonic loss in man is clearly the future challenge for developmental biologists and interested clinicians. The precise mutations that are embryonically lethal will have to be characterized and automated DNA-RNA screening techniques developed in order to take advantage of this information. The legacy of a decade of experimental recombinant molecular biology should ultimately provide the key to the critical human morphogenes and their mutant counterparts.
|Original language||English (US)|
|Number of pages||7|
|Journal||Seminars in Reproductive Endocrinology|
|Publication status||Published - Jan 1 1988|
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Reproductive Medicine